CompletedNCT07173465
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 77 Years
- Countries
- Turkey
- Sponsor
- Yeditepe University
- Condition
- Schizophrenia
CompletedNCT05278156
This study exists to understand whether the medication CPL500036 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication CPL500036 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Hungary, Poland, Ukraine
- Sponsor
- Celon Pharma SA
- Condition
- Schizophrenia
CompletedNCT07165821
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand what helps a medication treatment stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 20 Years to 59 Years
- Countries
- Thailand
- Sponsor
- Suranaree University of Technology
- Condition
- Schizophrenia
CompletedNCT06276361
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Jordan
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Condition
- Schizophrenia
CompletedNCT03681145
This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can work better when mental health difficulties overlap with substance use.
DepressionOtherFrom 18 Years to 29 Years
- Countries
- United States
- Sponsor
- University of California, San Francisco
- Condition
- Depression
CompletedNCT03314129
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Rochester
- Condition
- Schizophrenia
CompletedNCT07150507
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Turkey
- Sponsor
- Ataturk University
- Condition
- Schizophrenia
CompletedNCT04166019
This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Chinese University of Hong Kong
- Condition
- Schizophrenia
TerminatedNCT03121586
This study exists to understand how the medication Pimavanserin holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherOver 18 Years
- Countries
- Argentina, Bulgaria, Canada, Croatia, Czech Republic, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT04531982
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Argentina, Bulgaria, Croatia, Czech Republic, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
TerminatedNCT02853019
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
CompletedNCT07130227
This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand what psychoeducation, a guided learning and support program, could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Turkey
- Sponsor
- Ataturk University
- Condition
- Schizophrenia
CompletedNCT06574893
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Turkey
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Condition
- Schizophrenia
CompletedNCT07116850
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- China
- Sponsor
- The First Hospital of Hebei Medical University
- Condition
- Schizophrenia
CompletedNCT04325386
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 22 Years to 85 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT01490086
This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- India, Malaysia, Moldova, Philippines, United States
- Sponsor
- Reviva Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT07111689
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Saglik Bilimleri Universitesi
- Condition
- Schizophrenia
CompletedNCT04106427
This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Switzerland
- Sponsor
- University of Bern
- Condition
- Schizophrenia
CompletedNCT00373672
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Northwestern University
- Condition
- Schizophrenia
CompletedNCT07102069
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Tianjin Anding Hospital
- Condition
- Schizophrenia
TerminatedNCT05501405
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 10 Years to 50 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
TerminatedNCT03432000
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
CompletedNCT06253546
This study exists to better understand the safety of the medication TV-44749 and how manageable it feels in practice. Researchers are trying to understand whether the medication TV-44749 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- China
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Schizophrenia
TerminatedNCT06397950
This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- GCS CIPS
- Condition
- Schizophrenia
CompletedNCT04025905
This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia